November 14th 2023
Empirical antibiotic therapy in diabetic foot ulcer infections increases hospitalization and prolonged symptoms in patients being treated for lower limb cellulitis are common. Two recent papers examine the need for effective communication, the importance of objective findings in cellulitis management, and the benefits of culture-based antibiotic therapy in diabetic foot ulcer cases.
State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Top 5 Contagion® News Articles for July 2017
August 1st 2017The relationship between temperature and incidence of surgical site infections, progress towards an HIV vaccine, the cleanliness of your stethoscope, an explanation on how infection rates at Stanford Hospital are a canary in a coal mine, and an interactive visual map that depicts the HIV epidemic in the United States, make up the Top 5 news articles for the month of July 2017.
Read More
Top 5 Contagion® News Articles for the Week of July 9, 2017
July 15th 2017A new iteration of the American Health Care Act (AHCA), the challenge of sepsis in US hospitals, a predictive map that identifies which species are likely to harbor the next human virus, how one Canadian researcher mail-ordered his way to horsepox, and a focus on how gonorrhea is on the way to becoming untreatable comprise the top 5 articles of the week for the week.
Read More
Top 5 Contagion® News Articles for the Week of June 25, 2017
July 1st 2017Measles in Ontario, more endoscope-related infections, a study of postnatal Zika infections, research and development on a river blindness vaccine, and using CRISPR to tackle Zika are the articles that make up this week’s Top 5.
Read More
Top 5 Contagion® News Articles for the Week of June 18, 2017
June 24th 2017Pleuromutilin antibiotics, meningococcal disease, tuberculosis, a new fluoroquinolone to treat acute bacterial skin and skin structure infections, and WHO’s position on HPV vaccine recommendations makes up this week’s Top 5 articles.
Read More
University Mumps Outbreak Prevails Despite High 2-Dose MMR Coverage
April 27th 2017The University of Iowa experienced a large mumps outbreak last year, despite almost 100% adherence to 2-dose measles, mumps, rubella (MMR) vaccine schedule, which begs the question, is it time to start recommending a 3-dose schedule?
Read More